ArticleOncoimmunology
Potential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapy.
Peter S Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
cites it
ArticleOncoimmunology
Peter S Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.